Boothbay Fund Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Boothbay Fund Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-642,000	Closed	-$15.6M	–	2535
2023 Q1	$15.6M	Buy	642,000 +572,200	+820%	+$12.5M	0.32%	32
2022 Q4	$1.49M	Sell	69,800 -2,400	-3%	-$51.2K	0.03%	723
2022 Q3	$1.29M	Buy	72,200 +41,000	+131%	+$538K	0.03%	759
2022 Q2	$300K	Buy	+31,200	New	+$392K	0.01%	1463
2021 Q4	–	Sell	-19,900	Closed	-$323K	–	2336
2021 Q3	$323K	Buy	+19,900	New	+$217K	0.01%	1295
2016 Q3	–	Sell	-8,500	Closed	-$434K	–	827
2016 Q2	$434K	Buy	+8,500	New	+$422K	0.17%	160

Boothbay Fund Management's ISEE Position: Q3 2023 in Review

Boothbay Fund Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 101,000 shares — an estimated $3.97M sold.

Boothbay Fund Management first reported a position in ISEE in Q2 2018 and held it in 12 quarters. The position peaked at $4.45M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Boothbay Fund Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 101,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.97M.
Boothbay Fund Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
Boothbay Fund Management's IVERIC bio, Inc. Common Stock position peaked at $4.45M in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.